These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21948603)

  • 21. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
    Zhao SP; Peng DQ; Yu BL; Huo Y;
    Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of outcomes in acute coronary syndrome in patients receiving statins within 24 hours of onset versus at later times.
    Saab FA; Eagle KA; Kline-Rogers E; Fang J; Otten R; Mukherjee D;
    Am J Cardiol; 2004 Nov; 94(9):1166-8. PubMed ID: 15518612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of statins in secondary prevention of STEMI and NSTEMI: when to start with statin treatment?].
    Reiner E
    Acta Med Croatica; 2009 Feb; 63(1):75-9. PubMed ID: 19681468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Baseline Statin Use Among Older Adults Without Clinical Cardiovascular Disease in the SPRINT Trial.
    Huesch MD
    JAMA Intern Med; 2018 Apr; 178(4):560-561. PubMed ID: 29356825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early statin therapy in acute coronary syndromes: the successful cycle of evidence, guidelines, and implementation.
    Waters DD; Ku I
    J Am Coll Cardiol; 2009 Oct; 54(15):1434-7. PubMed ID: 19796736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Cannon CP; Braunwald E; McCabe CH; Rader DJ; Rouleau JL; Belder R; Joyal SV; Hill KA; Pfeffer MA; Skene AM;
    N Engl J Med; 2004 Apr; 350(15):1495-504. PubMed ID: 15007110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of loading dose of atorvastatin before percutaneous coronary intervention on periprocedural myocardial injury.
    Yu XL; Zhang HJ; Ren SD; Geng J; Wu TT; Chen WQ; Ji XP; Zhong L; Ge ZM
    Coron Artery Dis; 2011 Mar; 22(1):87-91. PubMed ID: 21169815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early statin therapy in acute coronary syndromes.
    Kinlay S
    Minerva Cardioangiol; 2003 Oct; 51(5):577-84. PubMed ID: 14551525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Who does not need a statin: too late in end-stage renal disease or heart failure?
    Laufs U; Custodis F; Böhm M
    Postgrad Med J; 2009 Apr; 85(1002):187-9. PubMed ID: 19417167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins for everyone--(even for those at low risk.) Experts are excited, but the question is whether benefits would outweigh costs.
    Duke Med Health News; 2009 Feb; 15(2):1, 11. PubMed ID: 19358321
    [No Abstract]   [Full Text] [Related]  

  • 32. [Statins in primary prevention - a must for the general practitioner?].
    Zoller M
    Praxis (Bern 1994); 2011 Jul; 100(14):859-60. PubMed ID: 21732299
    [No Abstract]   [Full Text] [Related]  

  • 33. Statins and risk of new-onset diabetes mellitus.
    Shah RV; Goldfine AB
    Circulation; 2012 Oct; 126(18):e282-4. PubMed ID: 23109518
    [No Abstract]   [Full Text] [Related]  

  • 34. Statins and advanced heart failure--alive but barely breathing after CORONA and GISSI-HF.
    Lavie CJ; Mehra MR
    Congest Heart Fail; 2009; 15(4):157-8. PubMed ID: 19627287
    [No Abstract]   [Full Text] [Related]  

  • 35. [Statines for all or individualized lipid lowering therapy?].
    Parhofer K
    MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
    [No Abstract]   [Full Text] [Related]  

  • 36. Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention.
    Kumar A; Cannon CP
    J Interv Cardiol; 2007 Dec; 20(6):447-57. PubMed ID: 18042049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.
    Fonseca FA; Izar MC
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1041-56. PubMed ID: 19764857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early time to benefit with intensive statin treatment: could it be the pleiotropic effects?
    Ray KK; Cannon CP
    Am J Cardiol; 2005 Sep; 96(5A):54F-60F. PubMed ID: 16126024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization.
    McCollam P; Etemad L
    J Invasive Cardiol; 2005 Jun; 17(6):307-11. PubMed ID: 16003005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Statins in practice of the vascular surgeon and cardiologist].
    Pokrovskiĭ AV; Suntsov DS
    Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.